A biocompatibility study on peritoneal dialysis solution bags for CAPD.
Numerous factors related to the composition of peritoneal dialysis solutions (PDS) contribute to the pathogenesis of peritoneal fibrosis during continuous ambulatory peritoneal dialysis (CAPD). They include high osmolarity, low pH, and the presence of lactate, which may be responsible for stimulating the proliferation of peritoneal fibroblasts (PF) and for the toxicity on the peritoneal mesothelial cells (PMC). Similar effects could be hypothesized for the plasticizers released from the PDS bags, usually made of polyvinyl chloride (PVC), such as the acid esters of phthalic acid, particularly bis-(2-ethylhexyl) phthalate (BEHP). Recently, however, new BEHP-free bags (Clear-Flex, Bieffe, Italy) made of three layers (polyethylene, nylon, and polypropylene) have been introduced. The aim of this work is to evaluate in vitro the effects of samples of PDS contained in PVC bags (Bieffe) and in Clear-Flex bags on the proliferative capacity of peritoneal fibroblasts and peritoneal mesothelial cells, and the release of interferon gamma (IFN gamma), interleukin-1 (IL-1) and prostaglandin E2 (PGE2) from peritoneal T lymphocytes (PTLs) and macrophages (PM phi s). Results have shown that in the presence of PDS samples contained in PVC bags, the proliferative capacity of peritoneal fibroblasts was higher than in Clear-Flexbags. There was also an increased release of IFN-gamma and IL-1 from PTLs and PM phi s (cytokines that stimulate the collagen synthesis) and a decreased release of PGE2 (cytokines which inhibit the collagen synthesis). An inhibiting action on peritoneal mesothelial cells was also seen.(ABSTRACT TRUNCATED AT 250 WORDS)
Carozzi
S
S
Nephrology and Dialysis Unit, St. Paul's Hospital, Savona, Italy.
Nasini
M G
MG
Schelotto
C
C
Caviglia
P M
PM
Santoni
O
O
Pietrucci
A
A
D001672:Biocompatible Materials; D002455:Cell Division / Q000187:drug effects; D015232:Dinoprostone / Q000096:biosynthesis; D005260:Female; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000096:biosynthesis; D007375:Interleukin-1 / Q000096:biosynthesis; D017737:Macrophages, Peritoneal / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009757:Nylons / Q000633:toxicity; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000295:instrumentation*; D010537:Peritoneum / Q000166:cytology; D010968:Plasticizers / Q000633:toxicity; D011095:Polyethylenes / Q000633:toxicity; D011126:Polypropylenes / Q000633:toxicity; D011143:Polyvinyl Chloride / Q000633:toxicity; D013601:T-Lymphocytes / Q000378:metabolism; D014511:Uremia / Q000628:therapy
D001672:Biocompatible Materials; D007375:Interleukin-1; D009757:Nylons; D010968:Plasticizers; D011095:Polyethylenes; D011126:Polypropylenes; D007371:Interferon-gamma; D011143:Polyvinyl Chloride; D015232:Dinoprostone